Search Results 301-310 of 10835 for Gilbert syndrome

1. Study To Evaluate The Efficacy And Safety Of Elafibranor In Patients With Primary Biliary Cholangitis (PBC) And Inadequate Response To Ursodeoxycholic Acid - Mayo Clinic

   Gilbert's Syndrome (due to interpretability of bilirubin levels); Screening CPK > ULN; Screening ALT or AST > 5 ULN; Screening total bilirubin > 2 ULN ...

2. A Study Evaluating Effectiveness And Safety Of FFX Versus Combination Of CPI-613 With MFFX In Patients With Metastatic Adenocarcinoma Of The Pancreas - Mayo Clinic

   ... Gilbert's syndrome Serum albumin > 3.0 g/dL. Adequate renal function: Serum creatinine clearance CLcr > 30 mL/min). Adequate coagulation function ...

3. Hepatopulmonary syndrome - Doctors and departments - Mayo Clinic

   This lung condition causes low oxygen levels and shortness of breath in people who have advanced liver disease.

4. A Study To Treat Patients With Dravet Syndrome Using ZX008 - Mayo Clinic

   The purpose of this study is to provide patients with Dravet Syndrome, who do not qualify for participation in one of the ongoing ZX008 clinical trials, to ...

5. A Study Of The Outcomes Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease - Mayo Clinic

   Direct bilirubin must be <2 mg/dL unless the elevation is known to be due to Gilbert syndrome or aGVHD within 3 days of enrollment. ALT/SGPT and AST/SGOT ...

6. Guillain-Barre Syndrome and Zika: Is There a Connection? - Mayo Clinic News Network

   GBS is a rare disorder in which the body's immune system attacks the nerves, causing numbness and weakness, and in severe cases, paralysis. Right now there is ...

7. WEE1 Inhibitor AZD1775 With Or Without Cytarabine In Treating Patients With Advanced Acute Myeloid Leukemia Or Myelodysplastic Syndrome - Mayo Clinic

   Participation eligibility · Patient population (histological or cytologically confirmed diagnosis) · Total bilirubin ≤ 1.5 mg/dL (except Gilbert's syndrome or ...

8. Alternate Doses And Dosing Schedules Of Belantamab Mafodotin For The Treatment Of Triple-Class Recurrent And/or Refractory Multiple Myeloma - Mayo Clinic

   NOTE: Stable chronic liver disease (including Gilbert's syndrome or asymptomatic gallstones) or hepatobiliary involvement of malignancy is acceptable if ...

9. Immunological Perturbation in Patients with Birt-Hogg-Dube Syndrome - Mayo Clinic

   About this study. The purpose of this study is to determine whether FLCN mutations affect immune cell homeostasis and function.

10. Hepatopulmonary syndrome - Doctors and departments - Mayo Clinic

    This lung condition causes low oxygen levels and shortness of breath in people who have advanced liver disease.